19
1
49
7
8
a
1b
1d
18
79
37
1d
2 29
1d
25
37
Jordana B. Cohen, MD, MSCE
9bAssociate Professor of Medicine (Renal-Electrolyte and Hypertension) at the Hospital of the University of Pennsylvania
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
40
4
3
3
1d
40
423 Guardian Drive
34 Blockley Hall 831
Philadelphia, PA 19104
26
34 Blockley Hall 831
Philadelphia, PA 19104
35
95
Email:
jco@pennmedicine.upenn.edu
12
jco@pennmedicine.upenn.edu
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 7 BS c
32 The College of New Jersey, 2006.
21 7 MD c
3c Rutgers - New Jersey Medical School, 2009.
21 9 MSCE c
33 University of Pennsylvania, 2015.
c
3
27
5
3
3
8d
Permanent link21 7 BS c
32 The College of New Jersey, 2006.
21 7 MD c
3c Rutgers - New Jersey Medical School, 2009.
21 9 MSCE c
33 University of Pennsylvania, 2015.
c
2 29
21
1e
1d
24
7
29
27
23
b9 Cohen JB: Rethinking Confirmatory Testing in Primary Aldosteronism. Ann Intern Med. 178(7): 1044-1045, Jul 2025.
f2 Shulman R, Yang W, Cohen DL, Reese PP, Cohen JB: Cardiac Effects of Renin-Angiotensin System Inhibitors in Nonproteinuric CKD. Hypertension. 81(10): 2082-2090, Oct 2024.
104 Passman J, Wall-Wieler E, Liu Y, Zheng F, Cohen JB: Antihypertensive Medication Use Trajectories after Bariatric Surgery: A Matched Cohort Study. Hypertension. 81(8): 1737-1746, Aug 2024.
be Cohen JB, Juraschek SP: Making Sense of Individual Responses to Sodium Reduction. JAMA. 330(23): 2251-2252, Dec 2023.
15c Cohen DL, Wachtel H, Vaidya A, Hundemer GL, Tezuka Y, Davio A, Turcu AF, Cohen JB: Primary Aldosteronism in Chronic Kidney Disease: Blood Pressure Control and Kidney and Cardiovascular Outcomes After Surgical vs. Medical Management. Hypertension. 80(10): 2187-2195, Oct 2023.
9d Cohen JB, Mitchell GF, Gill D, Burgess S, Rahman M, Hanff T, Ramachandran VS, Mutalik K, Townsend RR, Chirinos JA ad : Arterial Stiffness and Diabetes Mellitus Risk in the Framingham Heart Study and United Kingdom Biobank. Circ Res. 131(6): 545-554, Sep 2022.
225 Cohen JB, Marcum ZA, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Scharfstein D, Williamson J, Pajewski NM, Bress AP: Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Netw Open. 5(7): e2220680, Jul 2022.
d4 Cohen JB, Brady TM: Validation of Blood Pressure Device Accuracy: When the Bottom Line is Not Enough. Circulation. 145(2): 94-96, Jan 2022.
132 Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V: Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among US Veterans: A Retrospective Cohort Study. Ann Intern Med. 174(3): 289-297, Mar 2021.
2c
7
1d
1f
Selected Publications
25a Jones DW, Ferdinand KC, Taler SJ, Shimbo D, Abdalla M, Altieri MM, Bansal N, Bello NA, Bress AP, Carter J, Cohen JB, Collins KJ, Commodore-Mensah Y, Davis LL, Egan B, Khan SS, Lloyd-Jones DM, Mazurek Melnyk B, Mistry EA, Ogunniyi MO, Schott SL, Smith SC, Talbot AW, Vongpatanasin W, Watson KE, Whelton PK, Williamson JD: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Circulation. 152(11): e114-e218, Sep 2025.b9 Cohen JB: Rethinking Confirmatory Testing in Primary Aldosteronism. Ann Intern Med. 178(7): 1044-1045, Jul 2025.
f2 Shulman R, Yang W, Cohen DL, Reese PP, Cohen JB: Cardiac Effects of Renin-Angiotensin System Inhibitors in Nonproteinuric CKD. Hypertension. 81(10): 2082-2090, Oct 2024.
104 Passman J, Wall-Wieler E, Liu Y, Zheng F, Cohen JB: Antihypertensive Medication Use Trajectories after Bariatric Surgery: A Matched Cohort Study. Hypertension. 81(8): 1737-1746, Aug 2024.
be Cohen JB, Juraschek SP: Making Sense of Individual Responses to Sodium Reduction. JAMA. 330(23): 2251-2252, Dec 2023.
15c Cohen DL, Wachtel H, Vaidya A, Hundemer GL, Tezuka Y, Davio A, Turcu AF, Cohen JB: Primary Aldosteronism in Chronic Kidney Disease: Blood Pressure Control and Kidney and Cardiovascular Outcomes After Surgical vs. Medical Management. Hypertension. 80(10): 2187-2195, Oct 2023.
9d Cohen JB, Mitchell GF, Gill D, Burgess S, Rahman M, Hanff T, Ramachandran VS, Mutalik K, Townsend RR, Chirinos JA ad : Arterial Stiffness and Diabetes Mellitus Risk in the Framingham Heart Study and United Kingdom Biobank. Circ Res. 131(6): 545-554, Sep 2022.
225 Cohen JB, Marcum ZA, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Scharfstein D, Williamson J, Pajewski NM, Bress AP: Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Netw Open. 5(7): e2220680, Jul 2022.
d4 Cohen JB, Brady TM: Validation of Blood Pressure Device Accuracy: When the Bottom Line is Not Enough. Circulation. 145(2): 94-96, Jan 2022.
132 Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V: Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among US Veterans: A Retrospective Cohort Study. Ann Intern Med. 174(3): 289-297, Mar 2021.
2c